Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Sell
7,351
-687
-9% -$141K 0.08% 130
2025
Q4
$2.06M Sell
8,038
-100
-1% -$26.2K 0.13% 116
2025
Q3
$2.12M Hold
8,138
0.13% 118
2025
Q2
$1.99M Sell
8,138
-14,558
-64% -$3.63M 0.13% 118
2025
Q1
$6M Buy
22,696
+1,528
+7% +$413K 0.4% 56
2024
Q4
$5.37M Sell
21,168
-12,592
-37% -$3.38M 0.36% 62
2024
Q3
$10.7M Buy
33,760
+4,762
+16% +$1.7M 0.7% 36
2024
Q2
$10.8M Buy
28,998
+23,498
+427% +$7.93M 0.76% 34
2024
Q1
$1.91M Buy
5,500
+2,475
+82% +$938K 0.13% 114
2023
Q4
$1.38M Buy
+3,025
New +$1.49M 0.11% 110

Other funds holding HUM

S&CO Inc's HUM Position: Q1 2026 in Review

S&CO Inc reduced its Humana (HUM) stake by 8.5% in Q1 2026, selling an estimated $141K and leaving 7,351 shares worth $1.27M. The position accounts for 0.08% of the portfolio, ranked #130.

S&CO Inc first reported a position in HUM in Q4 2023 and has held it in 10 quarters since. The position peaked at $10.8M in Q2 2024. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • S&CO Inc held 7,351 shares of Humana worth $1.27M as of Q1 2026.
  • S&CO Inc sold 687 Humana shares in Q1 2026, an estimated $141K.
  • Humana made up 0.08% of S&CO Inc's portfolio in Q1 2026, its #130 holding.
  • S&CO Inc first reported a position in Humana in Q4 2023 and has held it in 10 quarters since.
  • S&CO Inc's Humana position peaked at $10.8M in Q2 2024.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on S&CO Inc's 13F filing for Q1 2026, filed 7 May 2026.